Trial Profile
Clinical Trials Insight: 700030519
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 15 Oct 2008
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics
- Sponsors Unigene Laboratories
- 12 Feb 2008 New trial record.